145 related articles for article (PubMed ID: 23726617)
1. The association between serum uric acid levels at 3 months after renal transplantation and the graft outcome in living donor renal transplantation.
Choi JY; Kwon OJ
Transplant Proc; 2013 May; 45(4):1548-52. PubMed ID: 23726617
[TBL] [Abstract][Full Text] [Related]
2. Uric acid is highly associated with kidney allograft survival in a time-varying analysis.
Weng SC; Shu KH; Tarng DC; Cheng CH; Chen CH; Yu TM; Chuang YW; Huang ST; Wu MJ
Transplant Proc; 2014; 46(2):505-10. PubMed ID: 24656000
[TBL] [Abstract][Full Text] [Related]
3. The independent association between serum uric acid and graft outcomes after kidney transplantation.
Haririan A; Nogueira JM; Zandi-Nejad K; Aiyer R; Hurley H; Cooper M; Klassen DK; Weir MR
Transplantation; 2010 Mar; 89(5):573-9. PubMed ID: 19997058
[TBL] [Abstract][Full Text] [Related]
4. Is uric acid a predictive factor for graft dysfunction in renal transplant recipients?
Akgul A; Bilgic A; Ibis A; Ozdemir FN; Arat Z; Haberal M
Transplant Proc; 2007 May; 39(4):1023-6. PubMed ID: 17524881
[TBL] [Abstract][Full Text] [Related]
5. Elderly renal transplant recipients and renal dysfunction: a risk factor for hyperuricemia.
Einollahi B; Einollahi H; Rostami Z
Exp Clin Transplant; 2011 Dec; 9(6):376-80. PubMed ID: 22142044
[TBL] [Abstract][Full Text] [Related]
6. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
[TBL] [Abstract][Full Text] [Related]
7. Preemptive kidney transplant from deceased donors: an advantage in relation to reduced waiting list.
Pérez-Flores I; Sánchez-Fructuoso A; Calvo N; Marques M; Anaya S; Ridao N; Rodríguez A; Barrientos A
Transplant Proc; 2007 Sep; 39(7):2123-4. PubMed ID: 17889112
[TBL] [Abstract][Full Text] [Related]
8. Frequency of hyperuricemia and effect of calcineurin inhibitors on serum uric acid levels in liver transplanted children.
Tumgor G; Arikan C; Kilic M; Aydogdu S
Pediatr Transplant; 2006 Sep; 10(6):665-8. PubMed ID: 16911488
[TBL] [Abstract][Full Text] [Related]
9. Renal transplantation in cyclosporine-treated recipients at the Singapore General Hospital.
Vathsala A; Woo KT
Clin Transpl; 1999; ():189-97. PubMed ID: 11038637
[TBL] [Abstract][Full Text] [Related]
10. A J-Shaped Association Between Serum Uric Acid Level and Allograft Outcomes After Living Donor Kidney Transplantation.
Oh IH; Kim JE; Lee CH; Kim GH; Park JS
Artif Organs; 2016 Feb; 40(2):136-43. PubMed ID: 26153484
[TBL] [Abstract][Full Text] [Related]
11. Preemptive living donor renal transplantation: a single-center experience.
Haberal M; Karakayali H; Sevmis S; Akbulut S; Colak T; Baskin E; Moray G; Torgay A; Arslan G
Transplant Proc; 2009 Sep; 41(7):2764-7. PubMed ID: 19765429
[TBL] [Abstract][Full Text] [Related]
12. [Living-donor kidney transplantation in the cyclosporine era].
Campise M; Tarantino A; Berardinelli L; Finazzi S; Montagnino G; Rossini G; Scalamogna M; Cesana B; Ponticelli C
G Ital Nefrol; 2002; 19(1):49-54. PubMed ID: 12165946
[TBL] [Abstract][Full Text] [Related]
13. Influence of cyclosporine and tacrolimus on serum uric acid levels in stable kidney transplant recipients.
Kanbay M; Akcay A; Huddam B; Usluogullari CA; Arat Z; Ozdemir FN; Haberal M
Transplant Proc; 2005 Sep; 37(7):3119-20. PubMed ID: 16213325
[TBL] [Abstract][Full Text] [Related]
14. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
Pietrzak-Nowacka M; Safranow K; Dziewanowski K; Debska-Slizień A; Głyda M; Gołembiewska E; Jankowska M; Nowosiad M; Rutkowski B; Ciechanowski K
Ann Acad Med Stetin; 2008; 54(1):41-8. PubMed ID: 19127808
[TBL] [Abstract][Full Text] [Related]
15. Long-term results with single pediatric donor kidney transplants in adult recipients.
Modlin C; Novick AC; Goormastic M; Hodge E; Mastrioanni B; Myles J
J Urol; 1996 Sep; 156(3):890-5. PubMed ID: 8709356
[TBL] [Abstract][Full Text] [Related]
16. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
Siu YP; Leung KT; Tong MK; Kwan TH
Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
[TBL] [Abstract][Full Text] [Related]
17. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
[TBL] [Abstract][Full Text] [Related]
18. Hyperuricemia after renal transplantation.
Gores PF; Fryd DS; Sutherland DE; Najarian JS; Simmons RL
Am J Surg; 1988 Nov; 156(5):397-400. PubMed ID: 3056057
[TBL] [Abstract][Full Text] [Related]
19. Hyperuricemia in adult renal allograft recipients: prevalence and predictors.
Malheiro J; Almeida M; Fonseca I; Martins LS; Pedroso S; Dias L; Henriques AC; Cabrita A
Transplant Proc; 2012 Oct; 44(8):2369-72. PubMed ID: 23026595
[TBL] [Abstract][Full Text] [Related]
20. The impact of post-transplant hemoglobin level on renal allograft outcome.
Choi JY; Kwon OJ
Transplant Proc; 2013 May; 45(4):1553-7. PubMed ID: 23726618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]